FDA Approves New Prostate Cancer Imaging Agent Gozellix®
Go back to FDA Approves New Prostate Cancer Imaging Agent Gozellix®| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 12.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.00 | 52 Week High | $2.18 | |||
| Open | $12.00 | 52 Week Low | $0.30 | |||
| Day High | $12.00 | P/E | N/A | |||
| Day Low | $12.00 | EPS | $-3.32 | |||
| Volume | 565 | |||||
| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 12.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.00 | 52 Week High | $2.18 | |||
| Open | $12.00 | 52 Week Low | $0.30 | |||
| Day High | $12.00 | P/E | N/A | |||
| Day Low | $12.00 | EPS | $-3.32 | |||
| Volume | 565 | |||||

